URGN logo

URGN
UroGen Pharma Ltd

2,280
Mkt Cap
$1.41B
Volume
364,372.00
52W High
$32.37
52W Low
$3.61
PE Ratio
-10.49
URGN Fundamentals
Price
$28.89
Prev Close
$29.88
Open
$29.84
50D MA
$22.89
Beta
1.10
Avg. Volume
772,253.02
EPS (Annual)
-$3.19
P/B
-11.33
Rev/Employee
$377,278.35
$1,135.16
Loading...
Loading...

About

UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
291

Frequently Asked Questions

What is Market Cap of UroGen Pharma Ltd?
What is the 52-week high for UroGen Pharma Ltd?
What is the 52-week low for UroGen Pharma Ltd?
What is UroGen Pharma Ltd stock price today?
What was UroGen Pharma Ltd stock price yesterday?
What is the PE ratio of UroGen Pharma Ltd?
What is the Price-to-Book ratio of UroGen Pharma Ltd?
What is the 50-day moving average of UroGen Pharma Ltd?
How many employees does UroGen Pharma Ltd have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available